Oladimeji Fashola

Oladimeji F. serves as Chief Technology Officer at Quantoom Biosciences since May 2023, overseeing technology roadmaps and global CMC strategies for critical materials production. Prior to this role, Oladimeji held the position of Associate Director of MSAT/Process Development at Vertex Pharmaceuticals, where responsibilities included leading a team in the development of gene-editing technologies and managing IND/NDA submissions. Experience also includes significant roles at TriLink BioTechnologies as Principal Staff Engineer and Engineering Manager, supporting the CMC activities for Pfizer's Covid-19 vaccines. Previous positions at CP Kelco, allnex, Streling Engineering, and Armstrong World Industries underscore expertise in process development, scale-up activities, and quality management practices. Oladimeji earned a Bachelor's degree in Chemical Engineering from the University of Illinois Chicago in 2008.